Clinical Trials

NCT06162221 | RECRUITING | PHASE1/PHASE2
616 participants

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-30
Start Date:
2024-01-18
Completion:
2027-06-30
Conditions
  • Non-Small Cell Lung Cancer, NSCLC
  • KRAS, NRAS, HRAS-mutated NSCLC
  • KRAS G12C-mutated Solid Tumors, Lung Cancer
  • Lung Cancer Stage IV, Advanced Solid Tumor, Cancer
  • RAS G12D-mutated NSCLC
Interventions
  • DRUG
No Results Yet
NCT06126640 | ACTIVE_NOT_RECRUITING | PHASE3
1615 participants

A Phase III, Active-Controlled Study of SHR-A1811 Versus Trastuzumab Emtansine (T-DM1) in HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2026-06-30
Start Date:
2023-11-20
Completion:
2030-04-30
Conditions
  • HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page